AU2002310106A1 - Breast homing peptides and methods of identifying same using aminopeptidase p - Google Patents

Breast homing peptides and methods of identifying same using aminopeptidase p

Info

Publication number
AU2002310106A1
AU2002310106A1 AU2002310106A AU2002310106A AU2002310106A1 AU 2002310106 A1 AU2002310106 A1 AU 2002310106A1 AU 2002310106 A AU2002310106 A AU 2002310106A AU 2002310106 A AU2002310106 A AU 2002310106A AU 2002310106 A1 AU2002310106 A1 AU 2002310106A1
Authority
AU
Australia
Prior art keywords
aminopeptidase
methods
homing peptides
identifying same
breast homing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002310106A
Inventor
Markus Essler
Erkki Ruoslahti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Publication of AU2002310106A1 publication Critical patent/AU2002310106A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
AU2002310106A 2001-06-01 2002-05-21 Breast homing peptides and methods of identifying same using aminopeptidase p Abandoned AU2002310106A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87234201A 2001-06-01 2001-06-01
US09/872,342 2001-06-01
PCT/US2002/016462 WO2002099379A2 (en) 2001-06-01 2002-05-21 Breast homing peptides and methods of identifying same using aminopeptidase p

Publications (1)

Publication Number Publication Date
AU2002310106A1 true AU2002310106A1 (en) 2002-12-16

Family

ID=25359386

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002310106A Abandoned AU2002310106A1 (en) 2001-06-01 2002-05-21 Breast homing peptides and methods of identifying same using aminopeptidase p

Country Status (2)

Country Link
AU (1) AU2002310106A1 (en)
WO (1) WO2002099379A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104575A2 (en) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0478101B1 (en) * 1990-09-24 2001-08-29 W.R. Grace & Co.-Conn. Therapeutic use of peptides having thrombospondin-like activity
IL105554A (en) * 1992-05-05 1999-08-17 Univ Leiden Peptides of human papilloma virus for use in human t cell response inducing compositions
JPH07507213A (en) * 1992-05-22 1995-08-10 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア Digestive defensins, their cDNA sequences and production methods, and their uses

Also Published As

Publication number Publication date
WO2002099379A2 (en) 2002-12-12
WO2002099379A3 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
EP1377587A4 (en) Protein phosphate inhibitors
AU2003267124A1 (en) Bh3 peptides and method of use thereof
AU2002258790A1 (en) Novel microarrays and methods of use thereof
AU2002362197A1 (en) Method of stabilizing protein
AU2002308701A1 (en) Novel alanine transaminase enzyme and methods of use
AU2002324965A1 (en) Artificial kidney and methods of using same
AU2002338428A1 (en) Methods and systems for identifying proteins
AU2001286059A1 (en) Automated identification of peptides
AU2002365202A1 (en) Synthetic genes for malarial proteins and methods of use
AU2002354502A1 (en) Fluorescent proteins
AU2002246346A1 (en) Method of identifying phosphoprotein
AU2003282338A8 (en) Determination of protein function
AU2003246614A1 (en) Novel use of lipopeptide preparations
AU2002310106A1 (en) Breast homing peptides and methods of identifying same using aminopeptidase p
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2002354363A1 (en) Method of activating protein
AU2003209735A1 (en) Filament-recruiting fluorescent proteins for the analysis and identification of protein-protein-interactions
AU4648900A (en) Improved method of identifying and locating immunobiologically-active linear peptides
AU2001267699A1 (en) Testing of leather
AU2002366640A1 (en) Detection and removal of lead using lead-binding proteins
AU2002214598A1 (en) Claspin proteins and methods of use thereof
AU2002324769A1 (en) Physalia fluorescent proteins
WO2003016502A9 (en) Tramdorins and methods of using tramdorins
AU2002358377A1 (en) High sensitivity protein workstation and techniques
AU2002364192A1 (en) Method of identifying novel proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase